Alternatives to Avidity Biosciences

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing carbon dioxide (CO2) reducing technology and converting CO2 and sunlight into organic compounds.

Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

BioGene Therapeutics is a life sciences company developing novel gene therapy solutions for metabolic disorders like diabetes and obesity.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A biotechnology company developing genetic therapies for rare disorders.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biopharmaceutical company focused on rare genetic diseases of obesity.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered breast cancer detection and risk assessment solutions.

Data-driven software solutions for precision medicine and pharmaceutical development.